Vaccine News and Research

Latest Vaccine News and Research

Travel data reveals top 20 cities at risk of Wuhan coronavirus spread

The Wuhan coronavirus or 2019-N-CoV has spread across the globe, including Australia, United States, Cambodia, Canada, France, Germany, Japan, Malaysia, Nepal, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, and Vietnam.

28 Jan 2020

BCG vaccine formulations vary widely in their characteristics, study shows

Each year, more than 100 million newborns around the world receive vaccinations against Mycobacterium tuberculosis, or TB, which infects about one-quarter of the world's population.

28 Jan 2020

Coronavirus spreads - Australian breakthrough

Novel coronavirus, temporarily named “2019-nCoV”, has affected over 4,600 persons across the world and is spreading at a rapid pace say experts. The World Health Organization and other health organizations have stepped up vigilance to detect and isolate the infection to contain outbreaks.

28 Jan 2020

What parents need to know about the HPV vaccine

The vaccine that prevents infection from human papillomavirus (HPV) is nothing short of a medical marvel.

28 Jan 2020

An old plant virus inspires the design of novel second-generation malaria vaccine

Scientists from the Walter Reed Army Institute of Research have demonstrated that a novel, second-generation malaria vaccine candidate based on the tobacco mosaic virus may offer protection against Plasmodium falciparum malaria in the upcoming issue of the journal Proceedings of the National Academy of Sciences.

27 Jan 2020

LSTM to host a high-level symposium ahead of major vaccine conference in London

On Thursday 26 March, the Liverpool School of Tropical Medicine will bring together high-level representatives from organizations like the World Health Organization and key stakeholders in the private and public sectors along with scientists and doctors.

27 Jan 2020

Clinical trial to test safety, effectiveness of mAb against malaria in healthy volunteers

A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.

27 Jan 2020

Coronavirus is getting stronger

Over the last couple of weeks, the coronavirus has spread to various cities in China, as well as other countries. The death toll has reached 80 while more than 2,000 people have been infected. Chine health experts warn that the ability of the virus to spread is getting stronger, warning people to become vigilant and protect themselves from contracting the illness.

26 Jan 2020

Robotic heart to replace human transplants on the horizon

Scientists are working to end the need for human heart transplants by 2028. A team of researchers in the UK, Cambridge, and the Netherlands are developing a robot heart that can pump blood through the circulatory network but is soft and pliable. The first working model should be ready for implantation into animals within the next 3 years, and into humans within the next 8 years.

26 Jan 2020

Coronavirus outbreak intensifies

Following an outbreak of infection by the novel coronavirus 2019 (2019-nCoV) which causes acute respiratory illness, in China, an emergency committee meeting was held on January 22 and 23, 2020, by the Director-General of the World Health Organization (WHO).

26 Jan 2020

First glioblastoma patient treated with genetically modified poliovirus at UH

University Hospitals Seidman Cancer Center treated its first patient in a new clinical trial to validate the groundbreaking effects of the poliovirus on glioblastoma, a deadly Grade IV cancer of the brain.

24 Jan 2020

Something far deadlier than the Wuhan virus lurks near you

There's a deadly virus spreading from state to state. It preys on the most vulnerable, striking the sick and the old without mercy. In just the past few months, it has claimed the lives of at least 39 children.

24 Jan 2020

Infectious disease expert explains about Wuhan coronavirus

A new coronavirus virus, likely first transmitted to people from animals at a market in the Chinese city of Wuhan, is making international headlines as disease detectives work to uncover what it is, how it's transmitted, and how deadly the virus actually is.

24 Jan 2020

NIAID officials describe steps to control coronavirus that recently originated in China

The new cluster of viral pneumonia cases originating in Wuhan, China, marks the third time in 20 years that a member of the large family of coronaviruses (CoVs) has jumped from animals to humans and sparked an outbreak.

24 Jan 2020

Routine Zika vaccination could help prevent suffering and save money

Global climate change has raised concerns that mosquito-borne diseases could become increasingly prevalent in the United States as warmer temperatures lead to increased mosquito activity.

23 Jan 2020

New vaccine against African swine fever appears to be more effective than previous vaccines

Government and academic investigators have developed a vaccine against African swine fever that appears to be far more effective than previously developed vaccines. The research appears this week in the Journal of Virology, a publication of the American Society for Microbiology.

23 Jan 2020

Emerging public health concern about Wuhan coronavirus

Since December, a new coronavirus that originated in Wuhan, China, has killed at least 17 people and sickened close to 600. Cases continue to spread globally, with one identified in Washington state.

23 Jan 2020

Study findings have implications for meningococcal B vaccine programs globally

The results of the B Part of It study – the largest meningococcal B herd immunity study ever conducted – are published today in the New England Journal of Medicine.

22 Jan 2020

UTHSC College of Pharmacy, Kroger Health partner to improve shingles vaccination completion rates

The College of Pharmacy at the University of Tennessee Health Science Center has partnered with Kroger Health, the healthcare arm of The Kroger Co., on a nationwide, randomized controlled study across more than 2,200 community pharmacy locations to improve second-dose vaccination completion rates for the shingles vaccine. Elements of the project are funded through a grant from GlaxoSmithKline.

22 Jan 2020

GlobalData: China can use the lessons learnt from SARS epidemic to control Wuhan coronavirus

Following the news that cases of people infected with the Wuhan coronavirus rose to more than 270 laboratory-confirmed cases and the virus may spread from human-to-human.

22 Jan 2020